BIOMAT Database Logo BIOMAT Database Logo

[Fluoroquinolone susceptibility of Pseudomonas aeruginosa strains isolated from clinical materials]. 2003

Zenobia Wydmuch, and Jerzy Pacha, and Małgorzata Kepa, and Robert D Wojtyczka, and Danuta Idzik, and Olga Skowronek-Ciołek, and Swietłana Głab, and Anna Góras-Zawiazalec
Katedra i Zakład Mikrobiologii Wydziału Farmaceutycznego SAM w Sosnowcu.

The goal of our research was an analysis of sensitivity of Pseudomonas aeruginosa to fluoroquinolones (SPX, PEF, UB, LOM, CIP, ENX, OFX, NOR). The sensitivity was tested by disk diffusion method, according to NCCLS standards. 120 strains isolated from hospitalized (76 strains) and outpatient clinic (44 strains) persons were tested. The highest sensitivity of strains was observed to norfloxacin (36.8% and 86.4% of strains, respectively) and ciprofloxacin (30.3% and 81.8%). None of tested microorganisms was sensitive to flumequine. Resistant strains, isolated from sick persons in outpatient clinics were fewer (13.6%) as compared to hospitalized persons (51.3%).

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone

Related Publications

Zenobia Wydmuch, and Jerzy Pacha, and Małgorzata Kepa, and Robert D Wojtyczka, and Danuta Idzik, and Olga Skowronek-Ciołek, and Swietłana Głab, and Anna Góras-Zawiazalec
[Serotypes and antibiotic susceptibility of Pseudomonas aeruginosa isolated from clinical materials].
February 1974, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Zenobia Wydmuch, and Jerzy Pacha, and Małgorzata Kepa, and Robert D Wojtyczka, and Danuta Idzik, and Olga Skowronek-Ciołek, and Swietłana Głab, and Anna Góras-Zawiazalec
Antimicrobial susceptibility survey of Pseudomonas aeruginosa strains isolated from clinical sources.
August 2004, Journal of the National Medical Association,
Zenobia Wydmuch, and Jerzy Pacha, and Małgorzata Kepa, and Robert D Wojtyczka, and Danuta Idzik, and Olga Skowronek-Ciołek, and Swietłana Głab, and Anna Góras-Zawiazalec
Susceptibility of Pseudomonas aeruginosa strains isolated from hospitalized children.
July 1986, The Journal of antimicrobial chemotherapy,
Zenobia Wydmuch, and Jerzy Pacha, and Małgorzata Kepa, and Robert D Wojtyczka, and Danuta Idzik, and Olga Skowronek-Ciołek, and Swietłana Głab, and Anna Góras-Zawiazalec
[Trends of fluoroquinolone-resistant strains isolated from clinical materials].
July 1988, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Zenobia Wydmuch, and Jerzy Pacha, and Małgorzata Kepa, and Robert D Wojtyczka, and Danuta Idzik, and Olga Skowronek-Ciołek, and Swietłana Głab, and Anna Góras-Zawiazalec
Pyocyanin preparation from Pseudomonas aeruginosa isolated from heterogeneous clinical materials.
January 1986, Folia microbiologica,
Zenobia Wydmuch, and Jerzy Pacha, and Małgorzata Kepa, and Robert D Wojtyczka, and Danuta Idzik, and Olga Skowronek-Ciołek, and Swietłana Głab, and Anna Góras-Zawiazalec
[Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
January 2004, Medycyna doswiadczalna i mikrobiologia,
Zenobia Wydmuch, and Jerzy Pacha, and Małgorzata Kepa, and Robert D Wojtyczka, and Danuta Idzik, and Olga Skowronek-Ciołek, and Swietłana Głab, and Anna Góras-Zawiazalec
Serotypes and antimicrobial susceptibility of Pseudomonas aeruginosa strains isolated from diseased dogs.
April 1990, Nihon juigaku zasshi. The Japanese journal of veterinary science,
Zenobia Wydmuch, and Jerzy Pacha, and Małgorzata Kepa, and Robert D Wojtyczka, and Danuta Idzik, and Olga Skowronek-Ciołek, and Swietłana Głab, and Anna Góras-Zawiazalec
Anticandidal activity of Pseudomonas aeruginosa strains isolated from clinical specimens.
January 2007, Mycoses,
Zenobia Wydmuch, and Jerzy Pacha, and Małgorzata Kepa, and Robert D Wojtyczka, and Danuta Idzik, and Olga Skowronek-Ciołek, and Swietłana Głab, and Anna Góras-Zawiazalec
[Susceptibility to arbekacin in Pseudomonas aeruginosa isolated from clinical specimens].
November 1993, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Zenobia Wydmuch, and Jerzy Pacha, and Małgorzata Kepa, and Robert D Wojtyczka, and Danuta Idzik, and Olga Skowronek-Ciołek, and Swietłana Głab, and Anna Góras-Zawiazalec
[Serotype and antibiotic sensitivity of Pseudomonas aeruginosa isolated from clinical materials].
September 1970, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Copied contents to your clipboard!